Lipocine Inc Revenue per Employee (LPCN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Lipocine Inc   (NASDAQ: LPCN)
 

Lipocine Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 1898.77% in the third quarter 2026, year on year to cumulative value of $4 million, Lipocine Inc 's revenue per employee grew on a trailing twelve months basis to $ 267,497, this is below the company average.
Within the Healthcare sector Employees of 434 other companies have achieved higher revenue per employee. While Lipocine Inc 's total ranking has deteriorated compared to the previous quarter from 2165 to 3164. Lipocine Inc has 14 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LPCN Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 1898.77 % -69.48 % 27.2 % -67.19 % -17.02 %
Sales per Employee (TTM) $ 267,497 112,104 143,015 141,191 308,764
LPCN's Total Ranking # 3164 # 2165 # 2300 # 958 #
Seq. Revenue Change 1104.67 % 59.22 % -89.58 % 899.69 % -81.6 %

LPCN Company Profile >> Back to LPCN Efficiency Comparisons >> Compare LPCN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 158
Healthcare Sector # 435
Overall Market # 3164

Revenue per Employee Statistics
High Average Low
$ 1,201,431 $ 342,125 $ -211,042
(Jun 30 2022)   (Sep 30 2020)



Financial Statements
Lipocine Inc 's Revenue MRQ $ 2 Millions Visit LPCN's Income Statement
Lipocine Inc 's Revenues TTM $ 4 Millions Visit LPCN's aggregate revenue growth
What are LPCN's Sales? Visit LPCN's Sales by Segment




Other Ratios
Lipocine Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
LPCN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for LPCN's Competitors
Revenue per Employee for LPCN's Suppliers
Revenue per Employee for LPCN's Customers

You may also want to know
LPCN's Sales Growth Rates LPCN's Pe Price to earnings ratio LPCN's Receivables Turnover Ratio LPCN's Stock Quote
LPCN's Net Income Growth Rates LPCN's Ps Price to Sales ratio LPCN's Sales per Employee LPCN's Asset Turnover Ratio
LPCN's Net Margin LPCN's Pb Price to Book ratio LPCN's Financial Strength Ratios LPCN's Dividend Payout Ratio
Date modified: 2026-11-06T12:59:48+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Dexcom Inc   459,900.90 $ 5,104.900  Million 11,100 
Medpace Holdings Inc   457,804.03 $ 2,838.385  Million 6,200 
Haemonetics Corporation  457,405.56 $ 1,382.737  Million 3,023 
Novocure Limited  451,955.14 $ 725.388  Million 1,605 
Omniab Inc   451,808.99 $ 40.211  Million 89 
Teladoc Health Inc   440,739.82 $ 2,468.143  Million 5,600 
Orthopediatrics Corp  437,981.73 $ 263.665  Million 602 
Vanda Pharmaceuticals Inc   430,165.10 $ 229.278  Million 533 
Axogen inc   429,141.48 $ 266.926  Million 622 
Idexx Laboratories Inc  423,970.45 $ 4,663.675  Million 11,000 
3m Company  417,305.79 $ 25,247.000  Million 60,500 
Bausch and Lomb Corp  416,769.23 $ 5,418.000  Million 13,000 
Regenxbio Inc   414,854.45 $ 153.911  Million 371 
Teva Pharmaceutical Industries Limited  412,960.24 $ 14,020.000  Million 33,950 
Lemaitre Vascular Inc   412,119.08 $ 269.938  Million 655 
Sotera Health Company  410,083.33 $ 1,230.250  Million 3,000 
Cryo cell International Inc   409,559.89 $ 31.127  Million 76 
Innovage Holding Corp   407,343.60 $ 1,018.359  Million 2,500 
Brightspring Health Services Inc   403,367.83 $ 9,479.144  Million 23,500 
Repligen Corp  402,805.00 $ 805.610  Million 2,000 
Strata Critical Medical Inc   393,386.02 $ 236.425  Million 601 
Iovance Biotherapeutics inc   388,700.51 $ 378.983  Million 975 
Pro dex Inc   386,300.97 $ 79.578  Million 206 
Edap Tms Sa  385,363.32 $ 111.370  Million 289 
Msa Safety Inc  380,326.42 $ 2,015.730  Million 5,300 
Mimedx Group Inc   375,449.26 $ 303.363  Million 808 
Avita Medical Inc   374,703.54 $ 84.683  Million 226 
Integra Lifesciences Holdings Corp  374,245.76 $ 1,656.786  Million 4,427 
Ge Healthcare Technologies Inc   368,111.11 $ 19,878.000  Million 54,000 
Boston Scientific Corporation  357,118.64 $ 21,070.000  Million 59,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.